Arjo AB (publ) listed on Nasdaq Stockholm
The medical device company Arjo AB (publ) (“Arjo”), formerly part of the Getinge Group, has today been listed on Nasdaq Stockholm and the company’s shares of series B have been admitted to trading.
At an Extraordinary General Meeting of Getinge AB on December 4, 2017, the shareholders resolved to distribute all of the shares in Arjo to the shareholders of Getinge. The Getinge Group is thereby divided into two listed companies, Getinge and Arjo, which is expected to increase the potential to successfully develop each business. All of the shares of the wholly owned subsidiary Arjo, including the underlying Group, will be distributed to Getinge shareholders according to the Lex ASEA rules* and shares of series B in Arjo have now been admitted to trading on Nasdaq Stockholm.
Arjo is a global supplier of medical devices and solutions that improve quality of life for people with reduced mobility and age-related health challenges. Arjo’s work is based on genuine care for peoples’ health and well-being, and contributes to a sustainable healthcare system — always with people in mind.
“As a standalone, independent company, Arjo can achieve what is required to develop the business in the right direction. With a clearer focus, we will have better opportunities to realize our strategy and efficiently develop products and solutions, and thus create positive customer and shareholder value” says Joacim Lindoff, President and CEO of Arjo.
Arjo was founded in 1957 in Eslöv by entrepreneur Arne Johansson. Arjo has since evolved into a global player in the market, with extensive knowledge about how to care for and improve quality of life for people with reduced mobility and age-related health challenges.
Today, Arjo operates in a market featuring stable and high demand. There is much to indicate that global demand for healthcare and elderly care will continue to rise in the foreseeable future. Growth is largely being driven by demographic factors such as an aging population and higher incidence of chronic diseases. The economic performance of emerging markets is also enabling more countries to develop advanced healthcare.
“I am very proud and honored. The organisation has done a fantastic job – this is a big day for us at Arjo. I look forward to an exciting and successful future with Arjo” concludes Joacim Lindoff.
* Lex ASEA means, in brief, that a parent company can, under certain circumstances, distribute the company’s shares in a subsidiary to its shareholders without any immediate Swedish taxation arising on the distribution for the shareholders.
For further information, please contact:
Executive Vice President
Marketing Communication and Public Relations
Tel: +46 (0)10 335 48 10
At Arjo, we are committed to improving the everyday lives of people affected by reduced mobility and age-related health challenges. With products and solutions that ensure ergonomic patient handling, personal hygiene, disinfection, diagnostics, and the effective prevention of pressure ulcers and venous thromboembolism, we help professionals across care environments to continually raise the standard of safe and dignified care. Arjo has over 5,900 employees worldwide and customers in over 60 countries. In 2016 the Arjo sales amounted to about SEK 8 billion. Arjo is listed on Nasdaq Stockholm and its head office is located in Malmö, Sweden. Everything we do, we do with people in mind. www.arjo.com